FDA Inspection 1291260 — CYCLE PHARMACEUTICALS LTD
The FDA completed an inspection of CYCLE PHARMACEUTICALS LTD on Sep 19, 2025 in Cambridge. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 19, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Cambridge (United Kingdom)
Additional Details
Postmarket Adverse Drug Experience (PADE)